Olumiant (baricitinib) - Eli Lilly
Treatment Of Eosinophilic Fasciitis With Baricitinib In The Setting Of Autoimmune Comorbidity And Corticosteroid Contraindication (ACAAI 2026) - Oct 28, 2026 - Abstract #M740; Pres time: Nov 13, 2026; 05:05 PM - 06:00 PM; Location: Phoenix Convention Center • North Halls 4–6 (Lower Level); Monitor 11; No abstract available 
Immunology
https://annualmeeting.acaai.org/2026/submit_abstract.cfm
 
Oct 28, 2026
 
Prev Next